Testosterone Levels and Cutibacterium

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-89
SponsorUniversity of Washington

About this trial

Phase 1: In 51 patients undergoing shoulder arthroplasties, total serum testosterone, free testosterone and sex hormone binding globulin levels obtained in the clinic before surgery were correlated with the levels of Cutibacterium on the skin in clinic, in the operating room prior to surgery, and in the skin incision.

Phase 2: The investigators wish to determine if preoperative serum testosterone levels are associated with risk for shoulder PJI (periprosthetic joint infection) in patients undergoing primary shoulder arthroplasty. Also to determine if preoperative serum testosterone levels are predictive of bacterial load of deep tissue cultures taken at the time of revision shoulder arthroplasty in patients undergoing primary shoulder arthroplasty.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients having elective shoulder arthroplasty

Disqualifiers

history of shoulder septic arthritis

antibiotic use within 3 months prior to surgery

recent treatment for acne

Lacked fluency in English

Trial population

Phase 1 and 2: Subjects will be adult patients who present to the UWMC Bone \& Joint Center for pre-operative appointments for elective shoulder arthroplasty.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

300 Participants
are grouped into 2 trial groups
Group A: Phase 1
Group B: Phase 2

Trial outcomes

Primary outcomes

1

Serum testosterone

Time frame
At pre-operative clinic appointment, typically within 30 days prior to surgery
2

Free testosterone

Time frame
At pre-operative clinic appointment, typically within 30 days prior to surgery
3

sex hormone binding globulin

Time frame
At pre-operative clinic appointment, typically within 30 days prior to surgery
4

Cutibacterium specimen value

Time frame
Skin swab at pre-operative clinic appointment, typically within 30 days prior to surgery

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.